Menglei Hao

Menglei Hao

Auto-generated profile, based on publicly available information

Menglei Hao

Sichuan University

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
YWYijun Wang
Yijun Wang
YWYaoling Wang
Yaoling Wang
YLYujie Luan
Yujie Luan
MHMenglei Hao
Menglei Hao
WYWenyuan Yin
Wenyuan Yin
JWJinhui Wu
Jinhui Wu
Background: Heart failure with preserved ejection fraction (HFpEF) and unstable angina (UA) often coexist in clinical practice, constituting a high-risk cardiovascular phenotype with a markedly increased incidence of major adverse cardiovascular events (MACEs). The identification of high-risk patients within this population is crucial for reducing complications, improving outcomes, and guiding clinical decision-making. Objective: This study aimed to develop and externally validate predictive models based on machine learning algorithms to estimate the risk of MACEs in patients with coexisting UA and HFpEF, and to construct an online risk calculator to support individualized prevention strategies. Methods: This multicenter cohort study included 4459 patients with both HFpEF and UA admitted to 7 hospitals across eastern, central, and western China between January 1, 2015, and December 31, 2021. Patients were divided into the derivation cohort (n=2923) and external validation cohort (n=1536) based on geographic regions. Clinical, laboratory, and imaging data were extracted from electronic medical records. Key predictors were identified using a hybrid feature selection method combining least absolute shrinkage and selection operator and Boruta algorithms. A total of 33 survival models were developed, including a variety of machine learning algorithms and survival analysis models. The model with the best concordance index (C-index) performance was deployed as a web-based risk calculator. Additionally, we assessed other performance indicators of the best-performing model, including the area under the receiver operating characteristic curve, accuracy, sensitivity, specificity, recall, F 1 -score, Brier scores, calibration curves, and decision curve analysis. Results: Using a combination of the least absolute shrinkage and selection operator regression and the Boruta algorithm, 7 key predictors were identified: diabetes mellitus, blood platelet count, triglyceride, systemic inflammatory response index, triglyceride-glucose–BMI, N-terminal pro-brain natriuretic peptide, and atherogenic index of plasma. The surv.xgboost.cox model was used to predict MACEs in patients with UA and HFpEF due to its superior C-index. The model demonstrated the following performance metrics in the external validation cohort: a C-index of 0.788; cumulative/dynamic area under the curve of 0.81; and area under the curve values at 20, 30, and 40 months of 0.809 (95% CI 0.745‐0.873), 0.784 (95% CI 0.745‐0.824), and 0.807 (95% CI 0.776‐0.838), respectively. The model exhibited satisfactory calibration and clinical utility in predicting 40-month MACEs. Model interpretability was enhanced using Shapley Additive Explanations for survival analysis to provide global and individual explanations. Furthermore, we converted the surv.xgboost.cox-based model into a publicly available tool for predicting 40-month MACEs, providing estimated probabilities based on the predictive indicators entered. Conclusions: We developed a surv.xgboost.cox-based predictive model for MACEs in patients with the dual phenotype of HFpEF and UA. We implemented this model as a web-based calculator to facilitate clinical application.

6 October 2026 in Journal of the American Heart Association
Verified
Journal Article
Closed access
YWYiJun Wang
YiJun Wang
YXYanan Xu
Yanan Xu
JPJin Peng
Jin Peng
MHMenglei Hao
Menglei Hao
LHLiying Huang
Liying Huang
JWJun Wang
Jun Wang
Background: Heart failure with preserved ejection fraction is a heterogeneous syndrome, and comorbid obstructive sleep apnea further increases the risk of acute coronary syndrome. However, effective tools for long‐term acute coronary syndrome risk stratification in this population remain limited. This study aimed to develop and externally validate a machine learning‐based prognostic model for predicting acute coronary syndrome risk at multiple time points in patients with heart failure with preserved ejection fraction and obstructive sleep apnea. Methods: We retrospectively enrolled 2272 patients with heart failure with preserved ejection fraction and obstructive sleep apnea from 2 tertiary hospitals. Candidate predictors from clinical characteristics, sleep monitoring, laboratory tests, and echocardiography were selected using least absolute shrinkage and selection operator regression and the Boruta algorithm. Thirty‐three survival models were developed, and the optimal model was selected based on the concordance index and externally validated. Results: Ten core predictors were identified, including metabolic, sleep‐related, and cardiac parameters. The accelerated oblique random survival forest model achieved the best discrimination among all evaluated models, with a concordance index of 0.731 in the external validation cohort. The model demonstrated good time‐dependent discrimination, with area under the curve values of 0.742, 0.734, and 0.755 at 20, 30, and 40 months, respectively. Calibration analyses and decision curve analysis supported its reliability and clinical utility. Conclusions: We developed and externally validated a machine learning‐based model for multitime‐point acute coronary syndrome risk prediction in patients with heart failure with preserved ejection fraction and obstructive sleep apnea. The accelerated oblique random survival forest model, implemented as a web‐based calculator, may facilitate individualized risk assessment and clinical decision‐making. Registration: URL: https://www.chictr.org.cn/ ; Unique Identifier: ChiCTR2300075727.